About U.L.S.S. 13
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at U.L.S.S. 13
During the past decade, U.L.S.S. 13 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "U.L.S.S. 13"
#1 collaborator was "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at U.L.S.S. 13
According to Clinical.Site data, the most researched conditions in "U.L.S.S. 13" are
"Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials), "Ovarian Cancer" (1 trials) and "Recurrent Ovarian Cancer" (1 trials). Many other conditions were trialed in "U.L.S.S. 13" in a lesser frequency.
Clinical Trials Intervention Types at U.L.S.S. 13
Most popular intervention types in "U.L.S.S. 13" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at U.L.S.S. 13
The vast majority of trials in "U.L.S.S. 13" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at U.L.S.S. 13
Currently, there are NaN active trials in "U.L.S.S. 13".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in U.L.S.S. 13,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in U.L.S.S. 13, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".